Miziverm, 2,5/25mg, Tablet
Miziverm, 2,5/25mg, Tablet
Authorised
- Milbemycin oxime
- Praziquantel
Product identification
Medicine name:
Miziverm, 2,5/25mg, Tablet
Active substance:
- Milbemycin oxime
- Praziquantel
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Milbemycin oxime2.50/milligram(s)1.00Tablet
-
Praziquantel25.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP54AB51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Latvia
Package description:
- Aluminum/Plastic Sachet 2 x 1.0 Tablet PET/Al/LDPE sachet
- Aluminum/Plastic Sachet 50 x 1.0 Tablet PET/Al/LDPE sachet
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Food And Veterinary Service
Authorisation number:
- V/DCP/26/0005
Date of authorisation status change:
Reference member state:
-
Czechia
Procedure number:
- CZ/V/0203/001
Concerned member states:
-
Bulgaria
-
Greece
-
Hungary
-
Latvia
-
Lithuania
-
Malta
-
Poland
-
Romania
-
Slovakia
Generic of:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 2/02/2026
Summary of Product Characteristics
English (PDF)
Download Published on: 14/03/2026
Package Leaflet
English (PDF)
Download Published on: 14/03/2026
Labelling
English (PDF)
Download Published on: 14/03/2026
eu-puar-czv0203001-mr-miziverm-en.pdf
English (PDF)
Download Published on: 14/03/2026
